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Hypertension-induced venous valve remodeling
Shinya Takase, MD,a Luigi Pascarella, MD,b John J. Bergan, MD,b and Geert W. Schmid-Scho¨nbein,
PhD,a La Jolla, Calif
Introduction: In human beings, chronic venous insufficiency is linked to venous hypertension. This in turn is associated
with venous valve incompetence. This study was designed to test the hypothesis that venous hypertension serves to initiate
a process that results in the venous valve and venous wall damage observed in venous insufficiency.
Material and methods: Acute venous hypertension was produced by creation of an arteriovenous (AV) fistula between the
femoral artery and vein in Wistar rats. At specified intervals pressure in the veins was recorded. The proximal valve
containing saphenous vein was exposed, and reflux was measured from reverse blood flow through the first proximal
valve. The vein was excised, valve parameters were measured, a portion was taken for morphologic investigation, and the
remaining specimen was frozen in liquid nitrogen for investigation of leukocyte infiltration, expression of adhesion
molecules, matrix metalloproteinase (MMP) levels, and apoptotic markers. Contralateral nonpressurized saphenous veins
were used as control specimens.
Results: The saphenous and femoral veins were immediately distended by pulsatile blood flow from the arterial system.
Pressure was significantly increased from 11  2 mm Hg to 94  9 mm Hg. At 2 days no reflux was detected in the
saphenous veins. At 1 week, one of four rats exhibited reflux; at 2 weeks, two of four rats had reflux; and at 3 weeks, three
of four rats showed reflux. Contralateral saphenous veins were uniformly competent. Compared with control specimens,
the veins were dilated; leaflet length and leaflet width were significantly reduced. Granulocytes, monocytes, and
macrophages were identified in all regions of the vein wall, and the number was increased by the presence of the AV fistula.
The number of T-lymphocytes was increased, and B-lymphocytes were present. P-selectin was upregulated in the
saphenous vein walls, as was intercellular adhesion molecules. MMP-2 and MMP-9 expression in the veins was not
enhanced. In the nuclear factor  family, Iwas not increased in any hypertensive veins. The number of apoptotic cells
in the vein wall was increased in the presence of the AV fistula.
Conclusion: This study indicates that acute venous hypertension is accompanied by significant venous distention and some
valve damage as early as 3 weeks after fistula creation. There is development of inflammatory markers, with leukocyte
infiltration and increased adhesion molecule expression. We could not detect significant enhancement of MMP levels or
nuclear transcription factors. It is uncertain whether this lack of evidence may be partially due to enhanced apoptosis in
venous valves and vein walls. A detailed definition of the inflammatory reaction produced by venous hypertension should
be the subject of further study. (J Vasc Surg 2004;39:1329-34.)
Clinical Relevance: Saphenous vein valves when observed at the time of vein stripping show deformities of shortening,
scarring, and tearing. The current model of induced venous hypertension demonstrates early venous valve changes similar
to those observed in human beings and links them to a venous hypertension–induced inflammatory reaction. Thus the
model could be useful in pharmacologic testing to prevent or treat venous insufficiency and for defining the fundamental
mechanisms that cause varicose veins.Valves are key regulators of blood flow and pressure in
veins. Profound alterations in venous valves have been seen
in surgical specimens and during angioscopy of the great
saphenous vein during vein surgery.1-3 Such alterations
include absence of the subterminal valve,3 thinning, elon-
gation, stretching, splitting, or tearing, and thickening,
retraction, and adhesion of valve leaflets.2 At the time of
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suggest complete remodeling of the valves that are usually
present in normal saphenous veins.3 Some investigators
have noted a decreased number of valves in the saphenous
vein in patients with varicose veins.4,5
Our recent intraoperative angioscopic observations and
gross morphologic studies in a selected small number of
postsurgical specimens have confirmed these changes in
venous valves.6 We found virtual disappearance of leaflets in
three of 10 specimens. Evidence of degenerated valve
stumps was present. Histologic investigation confirmed
proliferation of smooth muscle cells in three specimens, and
all tissue specimens showed clearly demarcated monocytes
and macrophages in the leaflet and the venous wall.
In addition to changes in valve anatomy, evidence of
inflammation was also observed. The number of monocytes
in the valve sinus and proximal vein wall was greater than in
the distal surface of the valves and the venous wall distal to
(upstream of) the valves. This localization of inflammatory1329
natom
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the valve leaflets and vein wall.
Accordingly, we investigated in an experimental model
the distribution of inflammatory markers in the vicinity of a
venous valve subjected to hypertension. We adopted a
model by van Bemmelen et al7 in the rat by creating an
arteriovenous (AV) fistula, and observed valvular incompe-
tence as well as destruction of commissures and the valve
sinus. In a related rat model of venous hypertension, Hahn
et al8 demonstrated an increase in leukocytes in areas of
venous hypertension. Thus the link between venous hyper-
tension, leukocyte infiltration, and tissue damage requires
further investigation.
This study was designed to test the hypothesis that
acute venous hypertension may produce morphologic
changes and inflammatory reactions in venous walls and
valves, including endothelial cell activation and attachment
of leukocytes.
MATERIAL AND METHODS
Animals and surgery. We produced venous hyperten-
sion by creating a fistula between the femoral artery and
vein in Wistar rats (Fig 1) under general anesthesia (pento-
barbital sodium, 50 mg/kg intramuscularly). Monofila-
ment sutures (9-0 to 12-0; Ethicon) were used to create the
fistula (0.5-mm inner diameter) between the femoral artery
and vein proximal to the saphenofemoral junction. The size
of the fistula was confirmed at tissue collection.
Blood pressure was measured in the vein distal to the
fistula. To avert cardiac failure after placement of the AV
fistula, tributaries to the femoral vein, including the super-
ficial epigastric vein near the anastomosis, were ligated. To
prevent blood coagulation, heparin was administered
Fig 1. Diagram of femoral vascular a(1000 U/kg body weight). The skin incision was closed,
and the rats were given intensive postsurgical care. The rats
were housed in a light-cycle controlled flow hood, and
maintained with standard pellet diet and water ad libitum.
The rats with the AV fistula were maintained for up to 3
weeks. The animal protocol was reviewed and approved by
the Animal Subjects Committee of the University of Cali-
fornia San Diego.
Valve reflux. At the end of selected observation peri-
ods the animals were given general anesthesia (pentobarbi-
tal sodium, 50 mg/kg intramuscularly). The contralateral
nonpressurized femoral vein and its enclosed valve was
collected as a control specimen and was subjected to the
same analyses as the pressurized vein and valve. Each fem-
oral vein was sectioned distal to its proximal valve. Reflux
through the valve was determined in situ for each rat with
timed collection of the backflow in the presence of the
native femoral pressure.
Valve anatomy. The femoral vein was mobilized and
opened longitudinally to permit examination of the valve
leaflet structure and shape. Morphologic measurements
obtained included length of vein half circle, valve height,
leaflet height, valve sinus length, edge length, and leaflet
width (Fig 2). The excised tissue was examined after hema-
toxylin-eosin staining.
Leukocyte infiltration and membrane adhesion
molecule expression. Valve specimens not subjected to
hematoxylin-eosin staining were freshly frozen in liquid
nitrogen and stored at70°C until examination. Longitu-
dinal sections (6-m thick) were cut across the valve leaflets
with a cryostat at23°C, air dried for 30 minutes, and fixed
in purified acetone for 9 minutes. Leukocyte infiltration,
expression of endothelial adhesion molecules, metallopro-
y in vicinity of arteriovenous fistula.
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frozen sections with antibodies against macrophages
(monoclonal Ab HIS36), T-lymphocytes (OX-52), B-
lymphocytes (OX-33), granulocytes (HIS 48), intercellular
adhesion molecule-1 (ICAM-1 [1A29]), the nuclear tran-
scription factor IB (Ab-2; Oncogene Research Product),
NFB proteins p50 (NFB1, Ab-1; Oncogene Research
Product), p65 (RelA, Ab-1; Oncogene Research Product),
MMP-2 (42-5D11; Oncogene) and MMP-9 (56-2A4,
Oncogene), and terminal deoxynucleotidyl transferase–
mediated (dUTP) nick end labeling; Trevigen kit TACS 2).
Secondary biotinylated antibodies were applied with perox-
idase-conjugated avidin to yield a dark brown reaction
product. The sections were examined with light micros-
copy at several magnifications up to 100 objective (nu-
merical aperture, 1.4). In addition to direct microscopic
observations, the expression of molecular markers was de-
termined with direct light absorption measurements after
image digitization on a laboratory computer (Power Mac;
Macintosh Computer) and expressed in terms of grade 0
(unstained), grade 1 (slightly stained), grade 2 (moderately
stained), and grade 3 (strongly stained).
Statistical analysis. All values are expressed as mean
SD. Differences between the pressurized valves and control
valves were analyzed with repeated measures analysis of
variance combined with a Scheffe-type multiple compari-
son test. P  .05 was considered significant. The analysis
was performed with Statview software (version 4.5 for
Macintosh; Abacus Concepts).
Fig 2. Diagram with designation of geometric parameters on
valve leaflets examined. 1, Half-circle; 2, valve height; 3, leaflet
height; 4, sinus length; 5, edge length; 6, leaflet width (maximum
leaflet height).RESULTS
On completion of the AV fistula, the saphenous vein
and femoral vein were immediately distended with pulsatile
blood flow from the arterial system. Pressure as measured in
the vein just distal to the fistula at creation was significantly
increased, from 11  2 mm Hg to 94  9 mm Hg.
Reflux. At 2 days no reflux was detected in the ex-
planted veins (n 3). At 1 week one of four veins exhibited
reflux; at 2 weeks two of four veins tested showed reflux;
and at 3 weeks three of four veins showed reflux (Fig 3).
Contralateral control saphenous veins were uniformly nor-
mal in anatomy, and were competent.
Vein anatomy. Observations were made on explanted
specimens at 3 weeks after creation of the AV fistulas.
Compared with control veins, the pressurized veins were
dilated. The length of the half-circle circumference was
increased approximately 25%. Leaflet height was signifi-
cantly reduced, as was leaflet width (Fig 4, A to E).
Leukocyte infiltration. Granulocytes were identified
in all regions of the vein wall, and the number was increased
by the presence of the AV fistula (Fig 5, A). The number of
monocytes and macrophages on pressurized valves was
greater than on control valves (Fig 5, B). The number of
T-lymphocytes was increased, and B-lymphocytes were
present. T-lymphocytes were markedly increased in the
valves subjected to high pressure (Fig 5, C).
Inflammatory markers. P-selectin was upregulated in
the saphenous vein walls (Fig 6, A), as was ICAM-1 (Fig 6,
B). MMP-2 and MMP-9 expression in the veins was not
enhanced.
In the NFB family, p50 and p65 were not increased in
any hypertensive veins. The number of apoptotic cells in the
vein wall was increased in the AV fistula group.
DISCUSSION
Venous hypertension and the inflammatory reaction
associated with valve remodeling are inextricably linked.
Fig 3. Reflux rates (mean  SD) in pressurized valves at 3 weeks
after arteriovenous fistula placement.
cont
JOURNAL OF VASCULAR SURGERY
June 20041332 Takase et alControl venous valves, unaffected by the pressure from the
AV fistula, remained normal over the observation period of
this study. In contrast, marked changes in valve anatomy
occur in veins with elevated pressure. Under observation at
low magnification these changes are similar to those noted
in incompetent saphenous veins.2 The length of the half-
circle vein arc is dilated. Leaflet height is significantly re-
duced. The edge length of the valve is increased. These
changes were also described by van Bemmelen et al,7 who
stated that “separation and leakage of the cusps were seen
along the entire free border.” In the present experimental
preparation no differences in valve sinus length were ob-
served between the control valves and valves exposed to
hypertension.
Granulocytes were seen in all regions of the venous wall
affected by the fistula. The number of granulocytes infil-
trating the venous wall was enhanced, as was the number of
T-lymphocytes, B-lymphocytes, and monocytes and mac-
rophages.
Fig 4. A, Valve half-circle length. B, Leaflet height. C, L
and pressurized valves. Solid bars, Control valves. For de
was considered significant.
Fig 5. Number of granulocytes (A), monocytes and
pressurized valves. Solid bars, Control valves. P  .05 vsIn surgical specimens removed at saphenous vein sur-
gery, only monocytes and macrophages were seen infiltrat-
ing the valves and the vein wall.6 Thus the cellular infiltrate
in the chronic state encountered in human beings differs
from that in the acute experimental preparation. In human
beings monocytes can be attracted by chemotactic factors
that do not necessarily attract neutrophils, including oxi-
dized products (eg, low-density lipoprotein) and tissue
breakdown products. The issue needs to be examined
further.
Several mechanisms of venous pressure elevation exist
in veins of the lower extremities in human beings. The
hydrostatic pressure generated by the weight of the blood
column from the right atrium transmitted through valveless
iliocaval veins and the venous pressure generated by ab-
dominal compression press directly on the terminal (most
proximal) saphenous valve. This valve, in turn, as it be-
comes incompetent, enables reflux and raises the pressure
more distally. The combined action of these mechanisms
width. D, Valve height. E, Valve edge length of control
n of geometric parameters see Fig 2. P  .05 vs control
ophages (B), and T-lymphocytes (C) on control and
rol was considered significant.eaflet
finitiomacr
signifi
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measuring pressure in calf muscle and calf veins in human
beings, Arnoldi9 found that calf muscle pressure during
contraction varies from 80 to 90 mm Hg. During relax-
ation these pressures dropped to 30 to 40 mmHg. He
concluded that “the venous circulation of the lower ex-
tremities is not a low pressure system during walking.”9
Thus the blood pressure exerted on the most proximal
femoral valve in the current experimental preparation is
comparable to venous pressure exerted against calf perfo-
rating veins in human beings during walking.
The expression of P-selectin on the endothelial cells in
the fistula-affected saphenous vein was elevated. However,
we could not detect significant enhancement of MMP-2 or
MMP-9 expression in the veins with fistulas at 3 weeks.
This observation is at variance with changes in MMP-1 and
MMP-2 expression in varicose saphenous veins in human
beings,10 and requires further investigation at other time
points. While the elevated blood pressure will passively
stretch the structures that make up a venous valve, the more
chronic restructuring requires destruction and rearrange-
ment of extracellular matrix components such as elastin,
collagen, laminin, and fibronectin by release of oxygen free
radicals and proteolytic MMPs.
Even though the venous valve is instantly stretched by
pressure elevation, reflow does not occur until later. Once
reflow starts, we expect a significant change in the flow
pattern in the valve, with a shift of the fluid shear stress on
the endothelial cells. Such shift in fluid shear stress can have
a strong effect on the gene expression pattern in endothelial
cells.11 Thus it is uncertain whether the initial distention
due to pressure or the following shift in fluid shear stress
during reflow, or a combination of these factors, leads to
endothelial cell activation, attachment and infiltration of
the leukocytes into the venous wall and valve leaflets, and
eventual apoptosis.
At angioscopic study of the saphenous veins at surgery,
the greater saphenous vein is often valveless from the
Fig 6. P-selectin (A) and ICAM-1 (B) levels in pressuriz
bars, Control valves. P  .05 vs control was consideredsaphenofemoral junction to the upper calf, where the first
normal valve appears. Clinical observations confirm this
whenever stripping instruments pass unimpeded from
groin to knee. Clinically, such veins are subjected to many
years of chronic venous hypertension, which allows time for
extensive valve remodeling to the point of total destruction.
CONCLUSION
This study indicates that acute venous hypertension is
accompanied by significant venous distention and some
valve damage as early as 3 weeks after fistula creation.
Inflammatory markers appear, along with leukocyte infil-
tration and increased adhesion molecule expression. We
could not detect significant enhancement of MMP levels or
nuclear transcription factors NFB. It is uncertain whether
this lack of evidence may be partially due to the enhanced
apoptosis in venous valves and vein wall. Further details of
the inflammatory cascade during venous hypertension need
to be studied to improve current interventions.
We thank Mr Barrick P.-W. Lo and Mr Jonathan M.
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